Incidence, Epidemiology, and Transformation of Ocular Myasthenia Gravis: A Population-Based Study

Overview of attention for article published in American Journal of Ophthalmology, May 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

policy: 1 policy source
twitter: 2 X users

facebook: 2 Facebook pages

Readers on

mendeley: 109 Mendeley

So far, Altmetric has seen 2 policy documents that reference this research output.

ravulizumab - Clinical and Pharmacoeconomic Combined Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 22 Apr 2024

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

ravulizumab - Clinical, Pharmacoeconomic and Ethics combined Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 08 Aug 2023

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.